Valuation GI Innovation, Inc.

Stocks

End-of-day quote Korea S.E. 27/10/2026			5-day change	1st Jan Change
7,030.00 ^KRW	-8.22%		-14.27%	-60.15%

04-24	GI Innovation Enters Melanoma First-Line Treatment Market with GI-102 Approval for Phase 2 Clinical Trial Direct Comparison with Keytruda	CI
03-20	GI Innovation And Johnson & Johnson Enter Clinical Supply Agreement For Prostate Cancer Combination Therapy	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	531,894	391,211	1,126,313
Change	-	-26.45%	187.9%
Enterprise Value (EV) ¹	490,884	387,772	1,091,686
Change	-	-21.01%	181.53%
P/E	-8.52x	-6.04x	-29.2x
PBR	7.42x	13.7x	9.67x
PEG	0.1x	-1.76x	0.5x
Capitalization / Revenue	100x	16,112x	193x
EV / Revenue	92.3x	15,970x	187x
EV / EBITDA	-9.82x	-8.59x	-29x
EV / EBIT	-9.21x	-8.04x	-26.9x
EV / FCF	-24.6x	-14.6x	-29.7x
FCF Yield	-4.07%	-6.87%	-3.37%
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-1,286	-1,330	-604.4
Distribution rate	-	-	-
Net sales ¹	5,319	24.28	5,838
EBITDA ¹	-49,975	-45,159	-37,646
EBIT ¹	-53,305	-48,260	-40,635
Net income ¹	-55,495	-58,784	-35,135
Net Debt ¹	-41,010	-3,440	-34,627
Reference price ²	10,954.55	8,027.27	17,640.00
Nbr of stocks (in thousands)	48,555	48,735	63,850
Announcement Date	29/02/24	01/03/25	01/03/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GI INNOVATION, INC.	-	-	-	-	372M
WUXI APPTEC CO., LTD.	18.07x	6.54x	12.9x	1.78%	65.28B
ARGENX SE	30.04x	7.96x	26.09x	0.05%	54.57B
LONZA GROUP AG	36.97x	6.56x	19.6x	0.88%	53.59B
IQVIA HOLDINGS INC.	34.86x	3.39x	14.64x	-.--%	45.03B
BEONE MEDICINES AG	48.82x	5.62x	30.9x	-.--%	42.17B
REVOLUTION MEDICINES, INC.	-19.09x	184.46x	-20.29x	-.--%	39.42B
CELLTRION, INC.	28.28x	8.04x	20.81x	0.38%	32.71B
WUXI BIOLOGICS (CAYMAN) INC.	27.72x	5.84x	15.15x	-.--%	24.01B
GENMAB A/S	36.39x	6.61x	22.07x	-.--%	26.5B
Average	26.90x	26.11x	15.76x	0.34%	38.36B
Weighted average by Cap.	26.69x	24.66x	15.94x	0.46%